Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026

البيانات

قدّمه

رايان ماكنزي (R)

تاريخ التقديم

2026-09-14

مجلس المنشأ

مجلس النواب

المجال

Health

آخر إجراء

2026-09-14 — Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

المشاركين في الرعاية

4

congress.gov

الملخص

لسه مافيش ملخص رسمي من CRS للمشروع ده.